Homeopathy
DOI: 10.1055/a-2636-4424
Original Research Article

Adherence to Prophylactic Use of Homeopathic Arsenicum album during COVID-19 in India: A Cross-Sectional Study in 23 Cities

Authors

  • Debadatta Nayak

    1   Department of Epidemic Cell, Central Council for Research in Homoeopathy, Janakpuri, New Delhi, India
  • Karanpreet Nahar

    2   Department of Clinical Research, Dr. D.P Rastogi Central Research Institute of Homoeopathy, Noida, Uttar Pradesh, India
  • Lovepreet Kaur

    1   Department of Epidemic Cell, Central Council for Research in Homoeopathy, Janakpuri, New Delhi, India
  • Smita Singh

    1   Department of Epidemic Cell, Central Council for Research in Homoeopathy, Janakpuri, New Delhi, India
  • Hima Bindu Ponnam

    3   Regional Research Institute of Homoeopathy, Vikrampuri, Habsiguda, Hyderabad, Telangana, India
  • Birendra Singh Rawat

    4   Regional Research Institute for Homoeopathy, Kharghar, Navi Mumbai, Maharashtra, India
  • Akhyaya Kumar Prusty

    5   Regional Research Institute for Homoeopathy, Puri, Odisha, India
  • Umakanta Prusty

    6   Drug Proving Unit, Dr. A.C. Homoeopathic Medical College and Hospital Unit-III, Bhubaneswar, Odisha, India
  • Liyi Karso

    7   Regional Research Institute for Homoeopathy Guwahati, Guwahati, India
  • Lipipushpa Debata

    8   Central Research Institute for Homoeopathy, Lucknow, Uttar Pradesh, India
  • Siva Prasad Goli

    9   Homoeopathy Research Institute for Disabilities, Chennai, Tamil Nadu, India
  • Baidurjya Bhattacharjee

    10   Regional Research Institute for Homoeopathy, Siliguri, Chhota Pathuram Jote, Darjeeling, West Bengal, India
  • Bezawada Brunda

    11   Regional Research Institute for Homoeopathy, Gudivada, Dr GGH Medical College Campus, Gudivada, Andhra Pradesh, India
  • Partha Pratim Pal

    12   Dr Anjali Chatterjee Regional Research Institute for Homoeopathy, Kolkata, West Bengal, India
  • Devarajan Karthikeyan

    13   Clinical Research Unit (H), Puducherry, Puducherry, India
  • Nidhi Mahajan

    14   Central Research Institute for Homoeopathy, Jaipur, Rajasthan, India
  • Guru Ravi Chandra Reddy

    15   Clinical Research Unit (H), Tirupati, India
  • Santi Adhikary

    16   Clinical Research unit (H), Port Blair, India
  • Santosh Tamang

    17   Clinical Research Unit (H), Gangtok, Sikkim, India
  • Amit Shrivastava

    18   Regional Research Institute for Homoeopathy, Imphal East, Manipur, India
  • Ratan Chandra Shil

    19   Regional Research Institute for Homoeopathy, Agartala, Tripura, India
  • Karunakara Moorthi

    20   National Homoeopathy Research Institute in Mental Health, Kottayam, Kerala, India
  • Vibha Kumari

    21   Clinical verification unit (H) Patna, Shree Gurugovind Singh Hospital, Patna, Bihar, India
  • Uttam Singh

    22   Clinical Research Unit (H), Civil Hospital, Dawrpui Aizawl, Mizoram, India
  • Nitin Kumar Saklani

    23   Regional Research Institute for Homoeopathy, New Shimla, Himachal Pradesh, India

Funding Information This study was funded by the Central Council for Research in Homoeopathy, New Delhi, India.
Preview

Abstract

Background

The Indian government, in response to the coronavirus disease 2019 (COVID-19) pandemic, initiated campaigns to use complementary therapies for its prevention and control, such as large-scale distribution of the homeopathic medicine, Arsenicum album 30C, as potential prophylactic for COVID-19. This study estimates the individual adherence to using this homeopathic prophylactic within the Indian urban population.

Methods

A multi-center, cross-sectional, study was conducted across 23 cities in 19 Indian states and union territories from September to November 2022. Participants aged 18 years and above, who had received Arsenicum album 30C within the past month, were included. Adherence was assessed through self-reports. Data were collected in a structured data collection form. Factors influencing adherence were analysed using logistic regression.

Results

A total of 23,101 participants completed the survey. Among the participants, 79.89% (n = 18,457) completed the prescribed three-dose regimen, demonstrating high adherence. Older adults (≥61 years) exhibited the highest adherence (84.63%), whereas younger individuals had lower adherence rates. Employment status, gender and socio-economic class were significant predictors of adherence. Participants with a lower perceived risk of COVID-19 showed higher adherence (adjusted odds ratio = 1.86; 95% confidence interval, 1.73 to 1.99; p < 0.0001). Adverse events were reported by 0.1% (n = 22) of participants, with no serious effects observed.

Conclusion

The high adherence to Arsenicum album 30C highlights the effectiveness of a structured government distribution program and the potential of homeopathy as a welcomed medication in aiming to enhance public health.



Publication History

Received: 28 January 2025

Accepted: 14 June 2025

Article published online:
07 October 2025

© 2025. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany